This is in line with our previous studies showing that the loss of CK2 activity decreases NG2 gene expression in human placenta pericytes and in human NG2-positive GBM cells due to the inhibitory action of the transcription factor Sp1 [19,20,42,43]. The gene discussed is CSPG4; the disease is glioblastoma.